Bethyl Laboratories
Mouse anti-Stathmin Monoclonal Antibody [BLGM166]New
Primary
Catalog #A501-166
TargetStathmin
HostMouse
CloneBLGM166
ReactivityHuman
ApplicationIHC
Image 1 of 1
local_shipping
This item has an estimated lead time of two weeks.
Product Description
Stathmin is involved in the regulation of the microtubule (MT) filament system by destabilizing microtubules. It prevents assembly and promotes disassembly of microtubules. Phosphorylation at Ser-16 may be required for axon formation during neurogenesis. Stathmin is also involved in the control of the learned and innate fear (By similarity) [taken from the Universal Protein Resource (UniProt) www.uniprot.org/uniprot/P16949].
Specifications
Clonality
Monoclonal
Clone
BLGM166
Host
Mouse
Isotype
IgM
Reactivity
Human
Format
Whole IgM
Conjugate Type
Unconjugated
Purity
Purified
Target Identity
TargetStathmin
Antigen Species
Human
Gene ID3925
Gene Symbol
STMN1
Gene Name
stathmin 1
Uniprot IDP16949
Protein Name
Stathmin
Alternate Names
C1orf215 • Lag • LAP18 • leukemia-associated phosphoprotein p18 • metablastin • oncoprotein 18 • OP18 • phosphoprotein 19 • phosphoprotein p19 • PP17 • PP19 • PR22 • prosolin • Protein Pr22 • SMN • stathmin • stathmin 1/oncoprotein 18 • testicular tissue protein Li 189 • transmembrane protein C1orf215
Product Information
Applications
IHC
Buffer
Tris-buffered Saline with 1% BSA and <0.1% Sodium Azide
Storage Conditions
2 - 8 °C
Physical State
Liquid
Shelf Life
1 year from date of receipt
Country of Origin
USA
Applications
Immunohistochemistry (IHC)1:50 to 1:200
Documents
Product DatasheetPDF · A501-166 · Lot 1 (current lot)Open
Product DatasheetPDF · A501-166 · Lot 1 (current lot)Open
Safety Data SheetPDF · A501-166Open
Services
Antibody Conjugation
Antibody and conjugate formats developed together, built to your specification.
Request CustomizationCustom Monoclonal Antibody Discovery Services
Full custom monoclonal development, from immunization through validation.
Explore Monoclonal DevelopmentVHH Discovery
Single-domain antibodies for structurally difficult targets a conventional monoclonal can't reach.
Explore VHH DiscoveryResources
1



